Eli Lilly and Company and Adverum Biotechnologies, Inc., a clinical-stage company pioneering the use of intravitreal gene therapy with the aim of preserving sight for life in highly prevalent ocular diseases, announced a definitive agreement for Lilly to acquire Adverum Biotechnologies, Inc. ("Adverum"), including its…
Avidity Biosciences, Inc., a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates to profoundly improve people's lives, announced that it has entered into a definitive merger agreement with Novartis AG ("Novartis") which has been unanimously appro…
Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, announced that it has successfully completed the acquisition of Prothya Biosolutions Belgium BV and its subsidiaries. This strategic move enhances Accord B.V.'s commitment to improving global access to plasma-derived medicines and strengthens its ability to m…
Innovent Biologics announced a strategic global collaboration with Takeda to advance next-generation IO and ADC cancer therapies, with the goal of developing potentially transformative cancer treatments to benefit patients worldwide. This partnership aims to leverage key synergies and accelerate the global developmen…
Techsomed Ltd., a pioneering medical AI-powered software company specializing in image-guided therapy is pleased to announce a collaboration with Medtronic, a global leader in healthcare technology. The pilot collaboration brings together Techsomed's BioTraceIO360™ software and the Medtronic Emprint™ microwave ablatio…
A.D.A.M. Innovations, Japan's leading private genetic testing company, and SOPHiA GENETICS, an AI technology company pioneering data-driven medicine, announced at ESMO a strategic agreement to bring cutting-edge liquid biopsy genomic testing to the Japanese population. The companies will also partner to commercialize…
SmartAlpha announced its collaboration with GE HealthCare to commercialize Nerveblox™, the company's initial AI solution designed to assist ultrasound-guided regional anesthesia. The technology met with U.S. anesthesiologists for the first time at the annual meeting of the American Society of Anesthesiologists (ASA) i…
Quintara Biosciences announced that it has completed the acquisition of Laragen Sanger Sequencing, formerly operated by Transnetyx, effective September 15, 2025. The acquisition ensures uninterrupted service for existing customers while reinforcing Quintara's strategic growth across California's life sciences corridor…
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced a strategic partnership with BlueWhale Bio, a commercial-stage company dedicated to transforming immune cell therapy manufacturing and addressing th…
Viatris Inc. a global healthcare company, announced it has acquired Aculys Pharma, Inc., a clinical stage biopharmaceutical company focused on commercializing innovative treatments for neurological conditions. Viatris received rights to develop and commercialize pitolisant and Spydia®, two assets in the Central Nervou…
Page 27 of 39